Higher levels of a metabolite called trimethylamine N-oxide (TMAO), produced by bacteria in the gut flora, are associated with an increased risk of heart failure.
Author and source information
This text is consistent with the requirements of medical literature, medical guidelines, and current studies and has been reviewed by medical professionals.
sources:
- WH Wilson Tang, Rosen N Lemaitre, Paul N Jensen, Meng Wang, Zhenning Wang, et al.: Trimethylamine N-oxide and gut microbiota-derived metabolites and the development of incident heart failure in populations; in: Circulation: Heart Failure (published August 9, 2024), Circulation: Heart failure
- Cleveland Clinic: Study by Cleveland Clinic, Tufts University highlights potential of using TMAO—a product of gut microbes—to predict heart failure risk (published August 13, 2024), Cleveland Clinic
Important Note:
This article contains general advice only and should not be used for self-diagnosis or treatment. It cannot replace a visit to your doctor.
“Total coffee aficionado. Travel buff. Music ninja. Bacon nerd. Beeraholic.”
More Stories
Exploding Fireball: Find the meteorite fragments
Neuralink's competitor lets blind people see again with an implant
A huge meteorite has hit Earth – four times the size of Mount Everest